SWOG clinical trial number
CTSU/C70807

The Men’s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance

Closed
Phase
Abbreviated Title
MEAL study
Status Notes
Permanent closure to pre-registration effective Friday, August 14, 2015 at 5:00 PM ET.
Activated
06/01/2011
Closed
08/14/2015
Participants
CTSU

Research committees

Cancer Survivorship
Genitourinary Cancer
Prevention & Epidemiology

Publication Information Expand/Collapse

2022

Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-Stage Prostate Cancer: The Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance])

JK Parsons;D Zahrieh;D Patel;J Mohler;R Chen;E Paskett;H Liu;E Peil;C Rock;O Hahn;J Taylor;P Van Veldhuizen;E Small;M Morris;M Naughton;J Pierce;J Marshall European Urology Focus Apr 30;S2405-4569(22)00061-X

PMid: PMID35504836

2020

Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial

JK Parsons;D Zarieh;J Mohler;E Paskett;D Hansel;A Kibel;H Liu;D Siesler;L Natarajan;O Hahn;J Taylor;E Small;P Van Veldhuizen;MJ Morris;M Bertagnolli;S Stroup;JP Pierce;JR Marshall Journal of the American Medical Association Jan 14;323(2):140-148

PMid: PMID31935026 | PMC number: PMC6990696

2018

The Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance]): A Randomized Clinical Trial of a Diet Intervention in Men on Active Surveillance for Prostate Cancer

JK Parsons;D Zarieh;J Pierce;J Mohler;E Paskett;D Hansel;A Kibel;O Hahn;J Taylor;L Hall;S Stroup;E Small;P Van Veldhuizen;MJ Morris;JR Marshall Journal of Urology April 199:4 Supplement, Page e1077 (AUA Annual Meeting, May 18-21, 2018, San Francisco), oral/plenary

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer

JK Parsons;JP Pierce;J Mohler;E Paskett;S-H Jung;MJ Morris;E Small;O Hahn;P Humphrey;JR Marshall British Journal of Urology International Apr;121(4):534-539

PMid: PMID28437029 | PMC number: PMC5654696

Other Clinical Trials

SWOG Clinical Trial Number
S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S2200

S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
Accrual
8%
Open
Phase
SWOG Clinical Trial Number
CTSU/A031901

Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial
Research Committee(s)
Genitourinary Cancer
Activated
05/01/2021
Open
Phase